New Zealand markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
106.06+2.12 (+2.04%)
At close: 04:00PM EDT
106.11 +0.05 (+0.05%)
After hours: 07:49PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
330,794
414,832
-224,060
-329,668
238,616
-
Depreciation & amortisation
644,719
638,696
629,471
552,483
278,253
-
Deferred income taxes
-260,541
-260,217
-292,251
69,198
-136,937
-
Stock-based compensation
231,930
226,841
221,996
189,006
120,998
-
Change in working capital
-166,363
-204,439
9,905
-47,952
-85,437
-
Accounts receivable
-88,786
-51,883
-90,135
-92,735
-38,647
-
Inventory
-19,998
-13,420
-49,642
-48,861
-30,537
-
Accounts payable
-44,280
9,603
-11,225
57,021
-18,935
-
Other working capital
983,484
1,049,045
773,783
732,975
520,394
-
Other non-cash items
180,775
204,167
741,027
325,772
327,578
-
Net cash provided by operating activities
1,038,528
1,092,007
1,271,977
778,507
899,648
-
Cash flows from investing activities
Investments in property, plant and equipment
-55,044
-42,962
-498,194
-45,532
-379,254
-
Acquisitions, net
-
0
0
-6,234,792
0
-
Purchases of investments
-765,100
-390,100
-61,036
-26,819
-2,397,675
-
Sales/maturities of investments
390,000
270,000
60,000
1,095,000
1,755,000
-
Other investing activities
-
-
-
-
14,259
-40,865
Net cash used for investing activities
-430,144
-163,062
-446,230
-5,212,143
-1,007,670
-
Cash flows from financing activities
Debt repayment
-31,000
-31,000
-582,014
-1,320,600
-889,575
-
Common stock repurchased
-
-269,761
-54
0
-146,537
-
Other financing activities
-56,982
-50,952
-45,443
-35,602
-16,877
-
Net cash used provided by (used for) financing activities
-332,018
-305,254
-529,491
3,970,522
528,073
-
Net change in cash
275,474
624,828
290,034
-466,321
420,425
-
Cash at beginning of period
1,167,911
881,482
591,448
1,057,769
637,344
-
Cash at end of period
1,444,277
1,506,310
881,482
591,448
1,057,769
-
Free cash flow
Operating cash flow
1,038,528
1,092,007
1,271,977
778,507
899,648
-
Capital expenditure
-55,044
-42,962
-498,194
-45,532
-379,254
-
Free cash flow
983,484
1,049,045
773,783
732,975
520,394
-